GI complications are common, second only to skin involvement, and affect up to 90% of systemic sclerosis (SSc) patients. PubMed. Expert Rev Gastroenterol Hepatol, 2013 May;7(4):331-9. (Also See: Scleroderma Gastrointestinal Involvement)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.